Consensus DexCom, Inc. CBOE

Stocks

DXCM

US2521311074

Medical Equipment, Supplies & Distribution

Market Closed - CBOE 06:59:51 10/10/26 am AEDT			5-day change	1st Jan Change
84.08 ^USD	-0.42%		-2.08%	+27.22%

08/10	Evercore ISI Adjusts Price Target on DexCom to $110 From $90	MT
01/10	RBC Raises Price Target on DexCom to $105 From $90, Keeps Outperform Rating	MT

5eae5.pGFgdhKqefIt1UtOGO4iu8V1_O9qswu7GRclFJqLiS8.xgAENVrIMbhOoS44UddAj_Yzz40Q0kGNdlpVWvnO4BnXFgEYWcNLvGOBIA~58cb0a71764bc48496bf69a53847988a

Analysts' recommendations: DexCom, Inc.

08/10	Evercore ISI Adjusts Price Target on DexCom to $110 From $90	MT
01/10	RBC Raises Price Target on DexCom to $105 From $90, Keeps Outperform Rating	MT
17/09	Truist Securities Adjusts DexCom Price Target to $102 From $93, Maintains Buy Rating	MT
13/08	Citigroup Adjusts Price Target on DexCom to $105 From $88, Maintains Buy Rating	MT
04/08	Argus Adjusts Price Target on DexCom to $96 From $86, Maintains Buy Rating	MT
04/08	UBS Adjusts Price Target on DexCom to $102 From $96, Maintains Buy Rating	MT
03/08	Rothschild & Co Redburn Adjusts Price Target on DexCom to $100 From $90, Maintains Buy Rating	MT
01/08	DexCom Glucose Monitors' National Coverage Could Support H2 Upside, RBC Capital Markets Says	MT
01/08	Leerink Partners Adjusts Price Target on DexCom to $94 From $80, Maintains Outperform Rating	MT
31/07	RBC Raises Price Target on DexCom to $90 From $85, Keeps Outperform Rating	MT
31/07	Canaccord Genuity Adjusts Price Target on DexCom to $90 From $82, Maintains Buy Rating	MT
31/07	Evercore ISI Adjusts Price Target on DexCom to $100 From $90, Maintains Outperform Rating	MT
31/07	Mizuho Adjusts Price Target on DexCom to $95 From $90, Maintains Outperform Rating	MT
31/07	Benchmark Adjusts Price Target on DexCom to $82 From $77, Maintains Buy Rating	MT
31/07	Bernstein Adjusts Price Target on DexCom to $90 From $77, Maintains Outperform Rating	MT
31/07	Deutsche Bank Adjusts DexCom Price Target to $92 From $86, Maintains Buy Rating	MT
31/07	Truist Raises Price Target on DexCom to $93 From $87, Keeps Buy Rating	MT
31/07	Baird Adjusts Price Target on DexCom to $105 From $80, Maintains Outperform Rating	MT
31/07	JPMorgan Adjusts Price Target on DexCom to $82 From $65, Maintains Neutral Rating	MT
31/07	Piper Sandler Adjusts Price Target on DexCom to $95 From $88, Maintains Overweight Rating	MT
31/07	Wells Fargo Adjusts Price Target on DexCom to $90 From $85, Maintains Overweight Rating	MT
31/07	Stifel Adjusts Price Target on DexCom to $95 From $90, Maintains Buy Rating	MT
31/07	Citigroup Adjusts Price Target on DexCom to $88 From $84, Maintains Buy Rating	MT
31/07	Jefferies Adjusts Price Target on DexCom to $115 From $112, Maintains Buy Rating	MT
31/07	BTIG Adjusts Price Target on DexCom to $90 From $80, Maintains Buy Rating	MT

More recommendations

Other Medical Equipment, Supplies & Distribution

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ABBOTT LABORATORIES					+22.57%
	MEDTRONIC PLC					+19.02%
	STRYKER CORPORATION					+32.2%
	ESSILORLUXOTTICA					+56.61%
	CENCORA, INC.					+15.11%
	HOYA CORPORATION					+20.68%
	BECTON, DICKINSON AND COMPANY					+6.2%
	IDEXX LABORATORIES, INC.					+36.67%
	DEXCOM, INC.					+14%
	Average					+24.79%
	Weighted average by Cap.					+25.51%